ABSTRACT
INTRODUCTION
Liver diseases have a variety of causes such as infections, parasites, nutrition deficiency, inborn errors, toxic substances and malignancy. Viral hepatitis is the major cause of liver disease in tropical areas including Egypt (1) . Liver fibrosis results from sustained activation of hepatic stellate cells (HSC) by oxidative stress and cytokines. It replaces damaged cells with an extracellular matrix (2) . If treated properly at fibrosis stage, cirrhosis can be prevented (3) . Liver cirrhosis is a critical stage of chronic liver diseases that can produce liver failure, portal hypertension and hepatocarcinoma. It is related to high morbidity/mortality rate. The induction of oxidative stress, mitochondrial dysfunction and depletion of antioxidant status is a relevant feature in the progression of liver cirrhosis and fibrosis (4,5) . The current treatments of liver cirrhosis are limited to the removal of the underlying injurious stimulus, e.g. viruses in cases involving viral hepatitis. However, no effective antifibrosis drugs are available at present (6) . Carbon tetrachloride (CCl 4 ) is widely used to induce hepatic fibrosis and cirrhosis in animal models (7) . In the past years, carbon tetrachloride was widely used as a dry cleaning solvent until it was recognized as a carcinogen. Today, it is primarily used as an organic solvent and thousands of workers are potentially exposed to this chemical (8) . Oxidative stress, free radical generation and lipid peroxidation have been postulated to participate in the molecular mechanism of CCl 4 induced hepatotoxicity (9) . Liver cell injury induced by carbon tetrachloride involves initially the metabolism of carbon tetrachloride to trichloromethyl free-radical by the mixed function oxidase system of the endoplasmic reticulum (10) .This trichloromethyl free radical (CCl 3 ), reacts rapidly with molecular oxygen to produce the trichloromethyl peroxyl radical (CCl 3 O 2 ) and that these highly toxic radicals are responsible for attacks on unsaturated fatty acids of phospholipids present in the cell membrane, leading to lipid peroxidation in the liver cells (11) . In this regard, the reduction of oxidative stress may be a useful approach to reduce cell injury, cirrhosis and fibrosis induced by CCl 4 in experimental models of liver fibrosis (12,13) . Many reports indicate that CCl 4 causes necrosis, fibrosis, mononuclear cell infiltration, steatosis and foamy degeneration of hepatocytes, increase in mitotic activity and cirrhosis in the liver (14,15,16) . CCl 4 has also been reported to cause apoptosis in liver cells (15,17,18,19) . Several lines of evidence suggest that oxidative stress plays an important role in the etiopathogenesis of hepatic fibrosis (20,21) . In attempting to limit the oxidative damage effect on hepatic cells, a number of antioxidants have been tested in experimental hepatic fibrosis models (22) . Melatonin (N-acetyl-5-methoxy-tryptamine), a lipophilic indoleamine derived from tryptophan, was long thought to be produced exclusively in the pineal gland, but it has recently been detected in many other tissues. It regulates circadian rhythms, sleep and immune system activity, and behaves as a free radical scavenger (23) . It also exerts cytoprotection in various experimental models of liver injury (24,25) . Melatonin has been proved to have the greatest impact not only on oxidative stress, but also on systems of defense against free radicals, restoring the oxidative balance in treated experimental animals (22,26) .
Aim of the work:
The aim of the present study was to examine the potential protective effect of exogenous melatonin cotreatment on liver tissue injury and oxidative stress processes during induction of early phase of liver fibrosis by carbon tetrachloride (CCl 4 ) injection in rats. Therefore, the current study investigated the changes in oxidative processes, liver enzymes and serum marker of fibrosis with or without melatonin administration to CCL4 treated rats. Additionally, a detailed histopathological examination of hepatic tissues of all rat groups was performed to study effect of melatonin administration on histological damage caused by CCl 4 injection.
MATERIALS & METHODS

Reagents:
Nacetyl-5-methoxytryptamine (melatonin) was purchased from Sigma-Aldrich GmbH, Germany. Carbon tetrachloride (CCl 4 ) obtained from El-Gomhorya Company, Cairo, Egypt. Kits for Hyaluronic Acid (HA) was supplied by New Test Company, Hyaluronic Acid (HA) test kit (Guechot et al., 2000) (27) . All other reagents were of analytical grade.
Animals:
Eighteen adult, female albino rats weighing 160-200 gram were obtained from the Animal House of Faculty of Medicine of Assiut University. Rats were housed in groups in temperature and humidity regulated room, with free access to food and water. They were randomly divided into 3 groups (n = 6): control group (group I), carbon tetrachloride (CCl 4 ) treated group (group II) and CCl 4 + melatonin co-treated group (group III). Rats in CCL 4 treatment groups were injected subcutaneously with sterile CCl 4 (2 ml/kg of body weight) in a ratio of 1:1 with olive oil twice a week for 8 weeks. Rats of group III injected with CCl 4 in the same manner as in group II and received intraperitoneal melatonin injection in a dose of 20 mg/kg twice a week for 8 weeks, starting from the beginning of CCl 4 injection. Rats in normal control group subcutaneously injected with saline and olive oil (in a ratio of 1:1) at the same dose and frequency as those in CCl 4 treated group.
After 8 weeks, all animals were sacrificed. An immediate laparotomy was performed for each animal in all groups. Blood was drawn from the abdominal aorta and livers were removed from all animals. Blood was collected into tubes and centrifuged. Serum was aspirated and frozen at -20 ºC until time of biochemical assay. Liver tissue was fixed in formalin and embedded in paraffin. At the end of the experiment, liver tissue samples from control rats (group I) showed normal lobular architecture with central veins and radiating hepatic cords ( Figure I ). Liver tissue samples from group II (CCl 4 treated group) showed hepatic cell degeneration, necrosis, collagen deposition and venous engorgement in the microcirculatory bed. Scattered fibrous threads appear every now and then in-between hepatic lobules (Figure 2 ). In group III (CCl 4 + melatonin treated group) however, hepatocyte degeneration, necrosis and infiltration of inflammatory cells were all apparently ameliorated. Collagen deposition was also markedly reduced with no apparently formed fibrous threads with normalization of the appearance of the microvascular bed (Figures 3). Compared with group II, the histological picture of the liver tissue of rats in melatonin co-treated group was significantly improved. A number of antioxidants have been tested in experimental liver fibrosis models in attempts to limit the oxidative damage (22) . In the current study administration of melatonin (20 mg/kg twice a week for 8 weeks from the beginning of CCl 4 injection) to rats of group III (CCl 4 + Melatonin group) induced significant reduction of mean serum levels of LPO and NO levels.
Additionally, significant increase in mean serum levels of both GSH-Px and SOD has been revealed in comparison with group II. These findings indicate that melatonin cotreatment with CCl 4 could decrease lipid peroxidation and free radical formation and lead to a substantial recovery of the major antioxidant enzymes, thus limiting oxidative damage to the liver and could be considered as a protective agent against liver injury. These results were in agreement with previous studies which recorded significant reduction of oxidative stress markers with marked increase in antioxidant levels after melatonin treatment in cases of hepatic intoxication The protective actions of melatonin may be due to the molecule itself and to its metabolites. The efficacy of melatonin in reducing oxidative stress is increased by the metabolites that produces while scavenging, i.e. cyclic 3-hydroxymelatonin (cyclic 3-OHM), N-acetyl-N2-formyl-5-methoxykuramine (AFMK), and -N1-acetyl-5-methoxykuramine (AFM), which also appear to be efficient scavengers. Thus, second and third generation metabolites of melatonin may well contribute to the ability of the parent molecule to protect against oxidative stress. Because of this melatonin, rather than scavenging a single radical, may neutralize a number of toxic reactions via an antioxidant cascade (55,56) . Different antioxidants have been tested in experimental liver fibrosis models to decrease oxidative damage. In a comparative study between the antioxidant protective effect of both melatonin and vitamin E, carried out by Montilla et al. (26) , they found that melatonin (at a much lower dose than vitamin E) was much more efficient than vitamin E in reducing the negative parameters of oxidative stress and provided a significantly greater hepatoprotective effect against the liver injury than did a much higher dose of vitamin E. Also, melatonin had a more potent effect in restoring antioxidative enzyme activities. They added that melatonin is an effective antioxidant and a free radical scavenger as it can cross biological membranes easily and reach all compartments within the cell due to its small size and high lipophilicity. Also, Rozov et al. (57) recorded that melatonin has a higher antioxidant efficiency than vitamin E and GSH, which are known as powerful antioxidants.
In the present study, hepatic damage induced by CCl 4 administration was evaluated by measuring serum level of some of hepatic enzymes as alanine amino transferase (ALT) and aspartate aminotransferase (AST). Rats of CCl 4 treated group (group II) showed significant increase of ALT and AST levels as compared to values of control group. After melatonin cotreatment to group III, a significant decrease of these hepatic enzymes was observed in all treated animals, which indicates that melatonin has a protective effect on hepatic cells after CCl 4 intoxication. reported that a single dose of CCl 4 induced hepatotoxicity manifested biochemically by significant elevation of activities of liver enzymes, such as ALT and AST. They added that there was marked reduction of hepatic enzyme activities after melatonin administration. In 2009, Hong et al. ( 
7)
proved that melatonin administration to CCl 4 treated rats (at a dose of 10 mg/kg) was effective in reducing serum ALT and AST levels, indicating that melatonin can protect liver and alleviate the progression of hepatic fibrosis.
In the current study, the fibrotic effect of CCl 4 on hepatic tissues of group II rats was assessed by measuring serum level of hyaluronic acid (HA). It is well known that HA is a good serum marker of hepatic fibrogenesis even at its early stage (61,14) . So, it is considered a good marker for detection of initial phase of hepatic fibrosis which help in early diagnosis of hepatic fibrogenesis and able to assess severity of liver disease as mentioned by Kopk-Aguiar et al. From all the above studies, it can be speculated that early inhibition of lipid peroxidation by using a proper antioxidant as melatonin may be the most important mechanism of reducing liver fibrosis.
In the present study, liver injury was assessed with biochemical and histological parameters. Histopathological examination of liver specimens in the CCl 4 treated rats (group II) showed that the liver structure was disrupted with dilated blood vessels, collagen deposition and more necrotic and fatty degenerated liver cells compared with the controls (figure 2). In group III (CCl 4 + melatonin), histological study of hepatic tissues showed that melatonin could obviously attenuate the extent of necrosis and reduce the histological signs of liver damage and fibrosis (figure 3), documenting a significant protective effect of melatonin against liver damage and fibrosis caused by CCl 4 injection. These findings are consistent with previously reported results suggested that melatonin could decrease the scores of hepatic fibrosis and serum ALT and AST levels in rats with hepatic injury caused by CCl 4 .
The present study revealed the hepatic protective effect of melatonin administration in case of CCl 4 -hepatic toxicity. The study also explained different mechanisms of this protective effect of melatonin mainly through decreasing oxidative stress and restoring antioxidative enzymes as well as its anti-fibrotic effect. Another mechanism of melatonin hepatic protective effect may be due to its antiapoptotic effect as stated by showed that melatonin, readily rescued mitochondria from oxidative stressinduced dysfunction and effectively prevented subsequent apoptotic events and death in rat brain astrocytes. So, it seems that melatonin reinforces its therapeutic potential to combat a variety of oxidative stress-induced mitochondrial dysfunctions as well as mitochondria-mediated apoptosis in various diseases.
In conclusion, our study shows that melatonin, which is a safe molecule without relevant noxious side effects, has a substantial hepatoprotective effect in a rat hepatic fibrosis model induced by a 8-weeks' CCl 4 regimen. The results of the biochemical and histological measurements reported in this study proved that co-administration of melatonin with CCl 4 was able to decreases oxidative stress, hepatic cell damage and liver fibrosis in rat liver during hepatic intoxication with CCl 4 . The protective effect of melatonin may be due to both its direct radical scavenging properties and indirect effects as a regulator of antioxidant systems. Therefore, the study proposes that melatonin may be a valuable drug for inhibition of unwanted fibrosis in patients exposed to different hepatotoxic agents. 
5-Poynard T, Mchutchison
